Journal profile · Biochemistry, Genetics and Molecular Biology-Genetics
Frontiers in Genome Editing
ISSN 2673-3439 · Frontiers Media S.A. · Switzerland
Frontiers in Genome Editing: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 5.9 (journal website); fully open access; APC charged, amount not published; median 67 days to acceptance (97 articles, last 24 months); 55 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Genome Editing is published by Frontiers Media S.A. and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are CRISPR and Genetic Engineering, Plant Virus Research Studies and Virus-based gene therapy research, together about 49.9% of its articles. Its main subfields are Molecular Biology and Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Genome Editing is a multidisciplinary journal that explores innovations in, and the applications of, genome and epigenome editing technologies within human health, animal science, and plant science. We encourage the submission of reviews, opinions, policy and ethics related to these topics. Led by Field Chief Editor Prof. David Jay Segal (University of California, USA), the journal is indexed in the Web of Science Emerging Sources Citation Index (ESCI), PubMed Central (PMC), Scopus and the DOAJ. Frontiers in Genome Editing welcomes research on existing and emerging genome editing technologies and their implications across wide-ranging areas of research, industry, and clinical translations. Fields of research welcome include, but are not limited to: genome editing in animals genome editing in cancer and immunology genome editing in human health and disease genome editing in plants genome editing tools and mechanisms. In addition, the journal is particularly interested in research covering existing and emerging gene editing technologies including but not limited to CRISPR/Cas systems, ZFNs, TALENs, meganucleases. The journal also welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 2: Zero Hunger and SDG 3: Good Health and Well-Being. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Genome Editing is committed to advancing developments in the field by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future. Frontiers in Genome Editing is a member of the Committee on Publication Ethics.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Genetics
Editorial board by country: none in mainland China; most named United States 9, France 2, India 1, Canada 1, Brazil 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology37.6%
- Plant Virus Research StudiesAgricultural and Biological Sciences7.3%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5%
- RNA regulation and diseaseBiochemistry, Genetics and Molecular Biology4.2%
- Animal Genetics and ReproductionBiochemistry, Genetics and Molecular Biology4.1%
- Chromosomal and Genetic VariationsAgricultural and Biological Sciences3.9%
- Insect symbiosis and bacterial influencesAgricultural and Biological Sciences3.8%
- Plant tissue culture and regenerationBiochemistry, Genetics and Molecular Biology3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5.9Publisher website ·
- CiteScore 2026-06
- 9.8LetPub ·
- CiteScore (publisher)
- 9.8Publisher website ·
- SJR 2026-06
- 1.35LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 41OpenAlex ·
- i10-index
- 165OpenAlex ·
- 2-year mean citedness
- 7.09OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 47LetPub ·
Articles by year OpenAlex count · 330 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 43 | 10 |
| 2025 | 55 | 55 | 391 |
| 2024 | 34 | 34 | 535 |
| 2023 | 59 | 59 | 1,052 |
| 2022 | 61 | 61 | 1,633 |
| 2021 | 50 | 50 | 1,906 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
67 daysMedian, submission to acceptance · P25–P75 49 days – 96 days
- Acceptance to online
- median 20 days (97 articles)
- Submission to online
- median 95 days
- Sample
- 97 articles with submission and acceptance dates (102 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 2,550 | Yes | CC BY | |
| OpenAlex | CHF 2,550 | — | — | |
| LetPub | USD 2,125 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures/tables published under CC-BY; permissions required for third-party copyrighted material. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under CC-BY v4.0; authors retain copyright. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Manuscripts must meet international English language standards. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-3439
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Genome Editing
What CAS zone is Frontiers in Genome Editing in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Genome Editing is in Zone 2 of Biology, and in Zone 2 of the minor category Biotechnology & Applied Microbiology / Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Genome Editing?
The journal's website gives an impact factor of 5.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 9.8, h-index 41.
How long does peer review take at Frontiers in Genome Editing?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 49–96 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Genome Editing?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Genome Editing based?
Of the 16 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), France (2) and India (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Genome Editing?
According to LetPub and DOAJ records, Frontiers in Genome Editing is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Genome Editing open access, and what is the APC?
Frontiers in Genome Editing is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .